A M Minihane
Overview
Explore the profile of A M Minihane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jennings A, Shannon O, Gillings R, Lee V, Elsworthy R, Bundy R, et al.
BMC Med
. 2024 Dec;
22(1):600.
PMID: 39716203
Background: Despite an urgent need for multi-domain lifestyle interventions to reduce dementia risk, there is a lack of interventions which are informed by theory- and evidence-based behaviour change strategies, and...
2.
Poppe M, Duffy L, Marchant N, Barber J, Hunter R, Bass N, et al.
Trials
. 2022 Jul;
23(1):596.
PMID: 35883143
Background: Large-scale trials of multidomain interventions show that modifying lifestyle and psychological risk factors can slow cognitive decline. We aim to determine if a lower intensity, personally tailored secondary dementia...
3.
Calabuig-Navarro M, Jackson K, Kemp C, Leake D, Walden C, Lovegrove J, et al.
Sci Rep
. 2017 Mar;
7:44119.
PMID: 28276521
At a population level APOE4 carriers (~25% Caucasians) are at higher risk of cardiovascular diseases. The penetrance of genotype is however variable and influenced by dietary fat composition, with the...
4.
Rodriguez-Ramiro I, Vauzour D, Minihane A
Proc Nutr Soc
. 2015 Nov;
75(1):47-60.
PMID: 26592314
Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic component of the metabolic syndrome and its prevalence is rapidly increasing due to its strong association with insulin resistance...
5.
Ewins B, Vassiliadou M, Minihane A, Rimbach G, Weinberg P
Genes Nutr
. 2008 Oct;
1(2):125-31.
PMID: 18850206
Dietary antioxidants can affect cellular processes relevant to chronic inflammatory diseases such as atherosclerosis. We have used non-standard techniques to quantify effects of the antioxidant soy isoflavones genistein and daidzein...
6.
Jackson K, Armah C, Minihane A
Biochem Soc Trans
. 2007 May;
35(Pt 3):451-3.
PMID: 17511625
With increasing recognition of the pivotal role of vascular dysfunction in the progression of atherosclerosis, the vasculature has emerged as an important target for dietary therapies. Recent studies have indicated...
7.
Minihane A, Jofre-Monseny L, Olano-Martin E, Rimbach G
Proc Nutr Soc
. 2007 May;
66(2):183-97.
PMID: 17466101
Cardiovascular risk is determined by the complex interactions between genetic and environmental factors. The apoE genotype represents the most-widely-studied single nucleotide polymorphism in relation to CVD risk, with >3600 publications...
8.
Lovegrove J, Brady L, Lesauvage S, Lovegrove S, Minihane A, Williams C
Int J Obes Relat Metab Disord
. 2003 Oct;
27(11):1373-82.
PMID: 14574349
Objective: To determine whether the positive statistical associations between measures of total and regional adiposity and measures of glucose, insulin and triacylglycerol (TAG) metabolism reported in Caucasian men, are also...
9.
Rimbach G, de Pascual-Teresa S, Ewins B, Matsugo S, Uchida Y, Minihane A, et al.
Xenobiotica
. 2003 Sep;
33(9):913-25.
PMID: 14514441
1. Soy isoflavones have been extensively studied because of their possible health-promoting effects. Genistein and daidzein, the major isoflavone aglycones, have received most attention; however, they undergo extensive metabolism in...
10.
Minihane A, Khan S, Talmud P, Williams D, Wright J, Murphy M, et al.
Int J Obes Relat Metab Disord
. 2000 Oct;
24(9):1097-106.
PMID: 11033977
Objective: To investigate the associations between indices of adiposity and cardiovascular risk factors in individuals with an atherogenic lipoprotein phenotype (ALP). Subjects: Fifty-five men, aged 34-69 y, body mass index...